Clinical Research trials increase treatment options available to the community and enhance quality care. There are currently 7 treatment protocols ongoing at Sturdy Memorial Hospital through the National Cancer Institute's Cancer and Leukemia Group B (CALGB). CALGB brings together clinical oncologists and laboratory investigators to develop better treatments for cancer. Since Sturdy Memorial Hospital was awarded affiliate status by the CALGB in 2003, our patients have had local access to trials formerly available only at larger medical centers.
As new treatment protocols are developed through the CALGB, they are reviewed by Sturdy Memorial's Institutional Review Board and must pass rigorous scrutiny to ensure that patients are offered options that may provide a benefit beyond that of standard therapy. Most trials compare a new agent, combination of agents, or intervention with the current standard therapy. Participants must meet eligibility criteria, and are fully informed of all their options.
All Massachusetts health insurers and Medicare recognize clinical trials of the National Cancer Institute, as mandated by legislation. Patients do not incur additional fees for participating in a trial that is hoped to improve their care.
Cancer patients who are interested in finding out more about their eligibility and possible benefits of a clinical trial may ask their oncologist or call the clinical research nurse at (508) 236-7059.
Our partner, Shields Radiation Oncology Center Mansfield, is a Radiation Therapy Oncology Group (RTOG) member and a part of the Clinical Trials Cooperative Group Program, which offers over 60 clinical trials. Click here to visit the trials section of the Center's website.